Pitolisant Hydrochloride Patent Expiration
Pitolisant Hydrochloride is Used for treating cataplexy in patients with narcolepsy. It was first introduced by Harmony Biosciences Llc
Pitolisant Hydrochloride Patents
Given below is the list of patents protecting Pitolisant Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Wakix | US8207197 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine | Mar 07, 2030 | Harmony |
| Wakix | US8486947 | Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands | Sep 26, 2029 | Harmony |
| Wakix | US8354430 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine | Feb 06, 2026 | Harmony |
| Wakix | US7910605 | Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications |
Sep 23, 2022
(Expired) | Harmony |
| Wakix | US7169928 | Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
Feb 02, 2020
(Expired) | Harmony |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pitolisant Hydrochloride's patents.
Latest Legal Activities on Pitolisant Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Pitolisant Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 15 Jul, 2024 | US8354430 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 21 Dec, 2023 | US8207197 |
| Email Notification Critical | 08 Aug, 2023 | US8207197 |
| Electronic Review Critical | 08 Aug, 2023 | US8207197 |
| Change in Power of Attorney (May Include Associate POA) Critical | 08 Aug, 2023 | US8207197 |
| Expire Patent Critical | 24 Apr, 2023 | US7910605 |
| Maintenance Fee Reminder Mailed Critical | 07 Nov, 2022 | US7910605 |
| Patent Term Extension Certificate Critical | 06 Oct, 2022 | US8207197 |
| Withdrawal of Application for PTE Critical | 30 Aug, 2022 | US8486947 |
| Notice of Final Determination -Election Required | 11 Jul, 2022 | US8486947 |
Pitolisant Hydrochloride's Family Patents
